Literature DB >> 29570591

Emergence of Nontuberculous Mycobacterial Lymphadenitis in Children After the Discontinuation of Mandatory Bacillus Calmette and GuÉrin Immunization in France.

Adèle Lacroix1, Caroline Piau2, Philippe Lanotte3, Anne Carricajo4, Aurelie Guillouzouic5, Olivia Peuchant6, Anne Cady7, Clarisse Dupin8, Marie-Sarah Fangous9, Christian Martin10, Marie-Estelle Cariou11, Florence Le Gall12, Pascale Bemer5, Pierre Tattevin1.   

Abstract

Eighty-five children were diagnosed with culture-confirmed nontuberculous mycobacterial cervical lymphadenitis within the MYCOMED surveillance network from 2004 to 2013. The mean incidence sharply increased from 0.57 to 3.7 per 100,000 children per year, after the discontinuation of mandatory bacillus Calmette and Guérin immunization in 2007. Cases were documented as Mycobacterium avium (62.3%), Mycobacterium intracellulare (15.3%) and Mycobacterium lentiflavum (12.9%). Outcome was favorable in all, with or without surgery or antimycobacterial treatment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29570591     DOI: 10.1097/INF.0000000000001977

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

Review 1.  Proposing BCG Vaccination for Mycobacterium avium ss. paratuberculosis (MAP) Associated Autoimmune Diseases.

Authors:  Coad Thomas Dow
Journal:  Microorganisms       Date:  2020-02-05

2.  Diagnosis of extrapulmonary tuberculosis using the MPT64 antigen detection test in a high-income low tuberculosis prevalence setting.

Authors:  Ida Marie Hoel; Lisbet Sviland; Heidi Syre; Anne Ma Dyrhol-Riise; Ingerid Skarstein; Peter Jebsen; Melissa Davidsen Jørstad; Harald Wiker; Tehmina Mustafa
Journal:  BMC Infect Dis       Date:  2020-02-12       Impact factor: 3.090

3.  Radiomics and machine learning for the diagnosis of pediatric cervical non-tuberculous mycobacterial lymphadenitis.

Authors:  Yarab Al Bulushi; Christine Saint-Martin; Nikesh Muthukrishnan; Farhad Maleki; Caroline Reinhold; Reza Forghani
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.996

Review 4.  BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.

Authors:  Alok K Singh; Mihai G Netea; William R Bishai
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

5.  Socio-Economic and Environmental Factors Related to Spatial Differences in Human Non-Tuberculous Mycobacterial Diseases in the Czech Republic.

Authors:  Helena Modrá; Vít Ulmann; Jan Caha; Dana Hübelová; Ondřej Konečný; Jana Svobodová; Ross Tim Weston; Ivo Pavlík
Journal:  Int J Environ Res Public Health       Date:  2019-10-17       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.